| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4afb8b01aa8de7e0b24a86713b23a18 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b7f9cb0acf9d7f54c0f32e9da8d6796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae39b71d556ec499a69c3aa11c9b6437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86796fbc9ec66289b8156a390be9f910
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71d6e5fb7d506f05c98bb9b3e0a44db3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_653aecc48f2378a0ef27abbeac9cdf5b |
| publicationDate |
2017-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3250220-A1 |
| titleOfInvention |
Agonists of the nogo-a s1pr pathway for the treatment of glioblastoma |
| abstract |
The invention relates to the use of an extracellular domain of Nogo selected from Nogo-A delta 20 and Nogo-66 for the treatment of glioblastoma, particularly by intravenous or intrathecal administration. |
| priorityDate |
2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |